Entera Bio
(NASDAQ) ENTX
Entera Bio Financials at a Glance
Market Cap
$51.75M
Revenue (TTM)
$42.00K
Net Income (TTM)
$11.44M
EPS (TTM)
$-0.25
P/E Ratio
-4.45
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$1.15
Volume
306
Open
$1.09
Price
$1.15
Volume
306
Open
$1.09
Previous Close
$1.15
Daily Range
$1.09 - $1.19
52-Week Range
$0.91 - $3.22
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$1.15
Volume
306
Open
$1.09
Previous Close
$1.15
Daily Range
$1.09 - $1.19
52-Week Range
$0.91 - $3.22
ENTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Entera Bio
Industry
Biotechnology
Sector
Health CareEmployees
22
CEO
Miranda J. Toledano, MBA
Website
www.enterabio.comHeadquarters
Jerusalem, 9112002, IL
ENTX Financials
Key Financial Metrics (TTM)
Gross Margin
-36%
Operating Margin
-275%
Net Income Margin
-272%
Return on Equity
-108%
Return on Capital
-84%
Return on Assets
-72%
Earnings Yield
-22.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$51.75M
Shares Outstanding
46.62M
Volume
306
Short Interest
0.00%
Avg. Volume
209.49K
Financials (TTM)
Gross Profit
$30.00K
Operating Income
$11.53M
EBITDA
$11.50M
Operating Cash Flow
$7.37M
Capital Expenditure
$107.00K
Free Cash Flow
$7.48M
Cash & ST Invst.
$7.11M
Total Debt
$490.00K
Entera Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$7.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$51.75M
N/A
Market Cap/Employee
$2.88M
N/A
Employees
18
N/A
Net Income
$3.02M
-27.9%
EBITDA
$3.04M
-30.5%
Quarterly Fundamentals
Net Cash
$6.62M
-21.1%
Accounts Receivable
$219.00K
+73.8%
Inventory
$0.00
N/A
Long Term Debt
$260.00K
+154.9%
Short Term Debt
$230.00K
+35.3%
Return on Assets
-71.53%
N/A
Return on Invested Capital
-83.60%
N/A
Free Cash Flow
$14.48M
-885.2%
Operating Cash Flow
$14.46M
-885.3%